Webinar on Use of Dry Heat to Support Single-User Reuse of Certain Respirators

Join us on Tuesday, Jan 26, at 12 p.m. ET for the next webinar in the series.

If your email program has trouble displaying this email, view as a webpage. Join Us: Webinar on Use of Dry Heat to Support Single-User Reuse of Certain Respirators On Tuesday, January 26, 12:00 p.m.-1:00 p.m. ET, the U.S. Food and Drug Administration (FDA) will host a webinar on the Enforcement Policy for Bioburden Reduction Systems Using Dry Heat to Support Single-User Reuse of Certain Filtering Facepiece Respirators During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency. This webinar is part of the series on Respirators and Other Personal Protective Equipment (PPE) for Health Care Personnel Use during the COVID-19 Pandemic. Representatives from the FDA, the Centers for Disease Control and Prevention's (CDC) National Institute for Occupational Safety and Health (NIOSH), and Occupational Safety and Health Administration (OSHA) will be available to answer your questions. We encourage all interested stakeholders to join. Registration is not necessary. To ensure you are connected, please dial in at 11:45 a.m. U.S. Callers Dial: 888-455-1392 Conference number: PWXW1934848 Audience passcode: 7652118 International Callers Dial: 1-773-799-3847 Conference number: PWXW1934848 Audience passcode: 7652118 To view the slide presentation during the webinar: https://www.mymeetings.com/nc/join.php?i=PWXW1934848&p=7652118&t=c View the Webinar Details SAVE THE DATE: The FDA hosts a webinar regularly to share information and answer your questions about respirators and other personal protective equipment (PPE). Save the date for the next webinar: February 23, 2021, from 12:00 pm-1:00 pm ET Previous Webinars in This Series Recordings, printable slides, and transcripts from previous webinars in this series are available on the FDA's website. Questions? If you have questions, please contact the Division of Industry and Consumer Education.

Manage Subscriptions  |  Unsubscribe All  |  Help

This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA